Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP421370.RANMRnsFdpnZj5WAT5MLWgS7LctWBnHfl_mUW25H8ZfLQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP421370.RANMRnsFdpnZj5WAT5MLWgS7LctWBnHfl_mUW25H8ZfLQ130_assertion type Assertion NP421370.RANMRnsFdpnZj5WAT5MLWgS7LctWBnHfl_mUW25H8ZfLQ130_head.
- NP421370.RANMRnsFdpnZj5WAT5MLWgS7LctWBnHfl_mUW25H8ZfLQ130_assertion description "[ARX mutation testing should be undertaken in children aged less than 1 year with Ohtahara syndrome and a movement disorder, and in infants with unexplained neurodegeneration, progressive white matter loss, and cortical atrophy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP421370.RANMRnsFdpnZj5WAT5MLWgS7LctWBnHfl_mUW25H8ZfLQ130_provenance.
- NP421370.RANMRnsFdpnZj5WAT5MLWgS7LctWBnHfl_mUW25H8ZfLQ130_assertion evidence source_evidence_literature NP421370.RANMRnsFdpnZj5WAT5MLWgS7LctWBnHfl_mUW25H8ZfLQ130_provenance.
- NP421370.RANMRnsFdpnZj5WAT5MLWgS7LctWBnHfl_mUW25H8ZfLQ130_assertion SIO_000772 19747203 NP421370.RANMRnsFdpnZj5WAT5MLWgS7LctWBnHfl_mUW25H8ZfLQ130_provenance.
- NP421370.RANMRnsFdpnZj5WAT5MLWgS7LctWBnHfl_mUW25H8ZfLQ130_assertion wasDerivedFrom befree-20140225 NP421370.RANMRnsFdpnZj5WAT5MLWgS7LctWBnHfl_mUW25H8ZfLQ130_provenance.
- NP421370.RANMRnsFdpnZj5WAT5MLWgS7LctWBnHfl_mUW25H8ZfLQ130_assertion wasGeneratedBy ECO_0000203 NP421370.RANMRnsFdpnZj5WAT5MLWgS7LctWBnHfl_mUW25H8ZfLQ130_provenance.